Business

"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Obtaining Orphan Drug Designation from the US FDA

"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Obtaining Orphan Drug Designation from the US FDA

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class AJuly 27, 20264
"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Obtaining Orphan Drug Designation from the US FDA

About this update from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

Announcement on Obtaining Orphan Drug Designation from the US FDA The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

More from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A

All Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A news →